✦ LIBER ✦

Oral Contraception Does Not Alter Single Dose Saquinavir Pharmacokinetics in Women

✍ Scribed by Margit Fröhlich; Jürgen Burhenne; Meret Martin-Facklam; Johanna Weiss; Michael Von Wolff; Thomas Strowitzki; Ingeborg Walter-Sack; Walter E. Haefeli MD

Book ID: 108640059
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 147 KB
Volume: 57
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2003.01983.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

St John’s wort extract (Ze 117) does not

St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive

✍ Liane Will-Shahab; Steffen Bauer; Ullrich Kunter; Ivar Roots; Axel Brattström 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 174 KB

St John’s wort extract (Ze 117) does not

St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive

✍ Liane Will-Shahab; Steffen Bauer; Ullrich Kunter; Ivar Roots; Axel Brattström 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 46 KB

Marked alterations in dose-dependent pre

Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives

✍ Legler, Udo F; Benet, Leslie Z 📂 Article 📅 1986 🏛 Nature Publishing Group 🌐 English ⚖ 429 KB

Ursodeoxycholic acid does not affect eth

Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives

✍ Ornella Baisini; Federica Benini; Felice Petraglia; Wilhelm Kuhnz; Santo Scalia; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

A single dose of azathioprine does not a

A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone

✍ F. J. Frey; F. Lozada; T. Guentert; B. M. Frey 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 415 KB

PHARMACOKINETICS AND SAFETY OF SINGLE IN

PHARMACOKINETICS AND SAFETY OF SINGLE INTRAVENOUS AND ORAL DOSES OF DOLASETRON MESYLATE IN HEALTHY WOMEN

✍ ANTHER C. F. KEUNG; HÉLÈNE LANDRIAULT; MARC LEFEBVRE; DENIS GOSSARD; ELLEN E. DE 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Twenty-four healthy women received 2´4 mg kg 71 dolasetron mesylate (1´8 mg kg 71 dolasetron base) by a 10 min intravenous administration and by oral administration. Pharmacokinetics of dolasetron and of its active reduced metabolite MDL 74 156 were monitored for 48 h in plasma. Urine was collected